MEDLIVE TECHNOLOGY CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.7 HKD | -0.46% |
|
+6.75% | +2.59% |
| Apr. 29 | Medlive Technology More than Doubles Profit in 2023 | MT |
| Mar. 25 | Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on June 24, 2024 | CI |
| Sales 2024 * | 517M 71.38M 558M | Sales 2025 * | 637M 88.03M 688M | Capitalization | 5.86B 809M 6.32B |
|---|---|---|---|---|---|
| Net income 2024 * | 240M 33.15M 259M | Net income 2025 * | 211M 29.15M 228M | EV / Sales 2024 * | 2.93 x |
| Net cash position 2024 * | 4.34B 600M 4.69B | Net cash position 2025 * | 4.41B 609M 4.76B | EV / Sales 2025 * | 2.27 x |
| P/E ratio 2024 * |
28.4
x | P/E ratio 2025 * |
29.9
x | Employees | 742 |
| Yield 2024 * |
1.78% | Yield 2025 * |
2.02% | Free-Float | 25.35% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.46% | ||
| 1 week | +6.75% | ||
| Current month | +4.44% | ||
| 1 month | +13.43% | ||
| 3 months | +44.04% | ||
| 6 months | +6.88% | ||
| Current year | +2.59% |
1 week
8.02
8.91
1 month
7.188.91
Current year
5.858.91
1 year
5.599.90
3 years
5.5947.00
5 years
5.5947.00
10 years
5.5947.00
| Managers | Title | Age | Since |
|---|---|---|---|
Li Ping Tian
CEO | Chief Executive Officer | 57 | 13-04-07 |
Li Xin Tian
FOU | Founder | 55 | 13-04-07 |
Jiang Nan
CTO | Chief Tech/Sci/R&D Officer | 36 | 13-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Richard Yeh
BRD | Director/Board Member | 56 | 21-07-13 |
Eiji Tsuchiya
BRD | Director/Board Member | 59 | 13-11-30 |
Li Xin Tian
FOU | Founder | 55 | 13-04-07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.67% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 8.7 | -0.46% | 585,000 |
| 24-05-02 | 8.74 | +4.92% | 639,000 |
| 24-04-30 | 8.33 | +2.08% | 317,000 |
| 24-04-29 | 8.16 | +0.12% | 308,000 |
| 24-04-26 | 8.15 | -1.45% | 369,500 |
Delayed Quote Hong Kong S.E., May 03, 2024 at 04:09 am EDT
More quotes
Medlive Technology Co Ltd is a China-based investment holding company mainly operates online professional physician platform. The Company mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The Company mainly conducts its business within domestic market.
Sector
Advertising & Marketing
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.06
CNY
Average target price
9.314
CNY
Spread / Average Target
+15.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.59% | 810M | |
| +24.70% | 28.23B | |
| +7.21% | 18.16B | |
| +2.85% | 12.97B | |
| -5.88% | 11.59B | |
| +7.92% | 10.94B | |
| +18.79% | 4.96B | |
| -11.04% | 3.8B | |
| +35.86% | 3.52B | |
| -4.13% | 3.26B |
- Stock Market
- Equities
- 2192 Stock
